Company / Capital Returned to Shareholders
Neogen Capital Returned to Shareholders History
FY2018-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$3.1M
FY2019
5-year range
-
FY2018-FY2019
Trend
+0.0%
vs FY2018
Sector context
#91 of 103
Health Care
What the data says
Neogen's capital returned to shareholders of $3M is lower than 88% of companies in the Health Care sector (FY2019).
Based on SEC 10-K filings.
$3M in FY2019.
Health Care sector context is included.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 103This company $3.1M Sector average $721.8M
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2019, capital returned to shareholders increased 0.0% year-over-year.
- Ranks #91 out of 103 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.59 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $3.1M | +0.0% |
| FY2018 | $3.1M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2019 · SEC 10-K · Updated Mar 28, 2026